# US 2025/0152522 A1 · Liquid dispersible curcuminoid compositions and methods of improving cognitive function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152522 A1
- Document ID: US20250152522A1
- Status: Published application
- Kind: A1
- Application number: 18/958,764
- Filed: 2024-11-25
- Published: 2025-05-15
- Earliest claimed: 2020-06-26
- Assignees: Pharmako Biotechnologies PTY Limited
- Applicants: Pharmako Biotechnologies Pty Ltd
- Inventors: George Kokkinis
- Web page: https://patentgrep.com/patent/US20250152522A1

## CPC

- A61K 31/12: Ketones
- A61K 33/26: Iron; Compounds thereof
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Brain-derived neurotrophic factor (BDNF) is known to be related to normal neuronal function and energy homeostasis, and increased levels of serum BDNF are associated with improved cognitive function, including learning and memory The present invention relates generally to a method of preparing compositions for increasing the serum levels of brain-derived neurotrophic factor (BDNF). In particular, the method relates to combining a curcuminoid or a derivative thereof with a dispersing agent under high shear, and administering the composition to a subject in need thereof to increase the serum levels of Brain-derived neurotrophic factor (BDNF) to improve cognitive function, wherein the composition may be co-administered with iron.

## Claims

### Claim 1

A composition comprising a liquid dispersible curcuminoid composition admixed with a source of iron comprising:
at least 18 mg elemental iron,
a dispersing agent, and
wherein the liquid dispersible curcuminoid composition is prepared by combining a curcuminoid with the dispersing agent whilst applying a shear force.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the dispersing agent comprises a carrier oil, a non-ionic surfactant and a solvent.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the dispersing agent comprises 30% (w/w)-90% (w/w) non-ionic surfactant.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the dispersing agent comprises 5% (w/w)-30% (w/w) carrier oil.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the dispersing agent comprises 1% (w/w)-10% (w/w) solvent.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the ratio of the curcuminoid and the dispersing agent is from about 10:1 to about 5:1.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the liquid dispersible curcuminoid composition comprises at least 70% (w/w), at least 80% (w/w), at least 85% (w/w), at least 90% (w/w), or at least 95% (w/w) total curcuminoids.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the liquid dispersible curcuminoid composition comprises curcumin.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the source of iron comprises at least 50% (w/w), at least 60% (w/w), at least 70% (w/w), at least 80% (w/w), or at least 90% (w/w) ferrous sulfate, ferrous gluconate, ferrous fumarate, or combinations thereof.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the source of iron comprises at least 15% (w/w), at least 20% (w/w), at least 25% (w/w), at least 30% (w/w), or 100% (w/w) elemental iron.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the ratio of the liquid dispersible curcuminoid composition and the source of iron is from about 10:1 to about 2:1.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the ratio of total curcuminoids and elemental iron is from about 30:1 to about 5:1.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition is to be used in increasing serum levels of BDNF in a subject and, wherein after administration to the subject, the curcuminoid and iron act synergistically to increase BDNF serum levels in the subject compared to administration of the same or equivalent doses of the liquid dispersible curcuminoid composition or the source of iron when administered alone.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the shear force is created by high-shear mixing and the high-shear mixing is achieved by milling, rotor-stator mixing, chopping, high-pressure homogenization or combinations thereof.

### Claim 15

A kit of parts comprising a liquid dispersible curcuminoid composition and a source of iron,
wherein the source of iron is a compound, composition or supplement that comprises at least 18 mg elemental iron,
wherein the liquid dispersible curcuminoid composition further comprises a dispersing agent, and
wherein the liquid dispersible curcuminoid composition is prepared by combining the curcuminoid with the dispersing agent whilst applying a shear force.

### Claim 16 (depends on 15)

The kit of claim 15, wherein the composition is to be used in increasing serum levels of BDNF in a subject by admixing the liquid dispersible curcuminoid composition and the source of iron, wherein after administration to the subject, the curcuminoid and iron act synergistically to increase BDNF serum levels in the subject compared to administration of the same or equivalent doses of the liquid dispersible curcuminoid composition or the source of iron when administered alone.

### Claim 17 (depends on 15)

The kit of claim 15, wherein the shear force is created by high-shear mixing and the high-shear mixing is achieved by milling, rotor-stator mixing, chopping, high-pressure homogenization or combinations thereof.

### Claim 18

A method of preparing a composition comprising a liquid dispersible curcuminoid composition admixed with a source of iron,
the method comprising combining a curcuminoid with a dispersing agent whilst applying a shear force to form a liquid dispersible curcuminoid composition, and admixing the liquid dispersible curcuminoid composition with a source of iron,
wherein the source of iron is a compound, composition or supplement that comprises at least 18 mg elemental iron.

### Claim 19 (depends on 18)

The method of claim 18, wherein the ratio of the curcuminoid and the dispersing agent is from about 10:1 to about 5:1.

### Claim 20 (depends on 18)

The method of claim 18, wherein the dispersing agent comprises:
30% (w/w)-90% (w/w) non-ionic surfactant,
5% (w/w)-30% (w/w) carrier oil, and
1% (w/w)-10% (w/w) solvent.

### Claim 21 (depends on 18)

The method of claim 18, wherein the shear force is created by high-shear mixing and the high-shear mixing is achieved by milling, rotor-stator mixing, chopping, high-pressure homogenization or combinations thereof.

### Claim 22 (depends on 18)

The method of claim 18, wherein, when administered to a subject, the admixture of the liquid dispersible curcuminoid and the source of iron in the composition acts synergistically to increase BDNF serum levels in the subject compared to administration of the same or equivalent doses of the liquid dispersible curcuminoid composition or the source of iron when administered alone.
